Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,206,861 papers from all fields of science
Search
Sign In
Create Free Account
PTT 119
Known as:
PTT-119
, PTT.119
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
ambamustine
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Increased cancericidal activity of PTT.119; a new synthetic bis-(2-chloroethyl)amino-l-phenylalanine derivative with carrier amino acids
M. Yagi
,
M. Zanjani
,
J. Holland
,
J. Bekesi
Cancer Chemotherapy and Pharmacology
2004
Corpus ID: 7855199
SummaryThe cancericidal efficacy of a new synthetic tripeptide was demonstrated using both in vitro cultures and in vivo…
Expand
2004
2004
Phase II study of a new alkylating agent (PTT-119) in resistant-relapsed non-Hodgkin's lymphomas
S. Tura
,
P. Mazza
,
+8 authors
R. Zanchini
Cancer Chemotherapy and Pharmacology
2004
Corpus ID: 31751160
SummaryIn a phase II study we evaluated the effect and toxicity of a new alkylating agent, PTT-119, in 26 patients with non…
Expand
1990
1990
Evidence for increased intracellular transport of m-sarcolysine (alkylating moiety) when combined with two amino acid analogs (PTT-119)
F. Verlicchi
,
S. Boschi
,
+4 authors
S. Tura
Blut
1990
Corpus ID: 24272092
SummaryPTT-119 is an antineoplastic agent in which an alkylating moiety, m-sarcolysine, is linked to two amino acid analogs…
Expand
1990
1990
Phase II cooperative study with a new alkylating drug, PTT-119, in the treatment of non-Hodgkin's lymphomas
F. Gherlinzoni
,
P. Mazza
,
+21 authors
E. Dini
Blut
1990
Corpus ID: 42900245
SummaryIn a phase II cooperative study involving eleven Italian haematological units, the efficacy and toxicity of a new…
Expand
1988
1988
Mammary tumor and melanoma cell transport of PTT.119, a bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids.
M. Yagi
,
K. Scanlon
,
S. E. Chin
,
J. Bekesi
Chemotherapy
1988
Corpus ID: 46856556
Uptake of the bifunctional alkylating agent, PTT.119, p-F-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met-ethoxy-HCl, by the MJY-alpha…
Expand
1988
1988
Pharmacokinetics of PTT-119 in man.
F. Pannuti
,
G. Coppi
,
F. Borella
,
A. Martoni
,
L. Urbano
,
B. Melotti
Chemioterapia : international journal of the…
1988
Corpus ID: 45357038
The pharmacokinetics of PTT-119, a new alkylating agent, was studied in 8 advanced cancer patients. PTT-119 disappeared rapidly…
Expand
1987
1987
Immunopharmacological studies of PTT.119, a new synthetic bis-(2-chloroethyl)amino-L-phenylalanine derivative.
M. Allegrucci
,
P. Ballerini
,
L. Romani
,
L. Frati
Immunopharmacology and immunotoxicology
1987
Corpus ID: 21526665
The new synthetic tripeptide p-F-Phe-m-bis-(2-chloro-ethyl)amino-Phe-Met-etoxy HCl, PTT.119, was studied for its effects on the…
Expand
1985
1985
Analytical and pharmacological studies on a new antineoplastic tripeptide, PTT 119
J. Roboz
,
J. Greaves
,
M. J. Yagi
,
J. Holland
,
George Bekesi
1985
Corpus ID: 3303789
The new synthetic tripeptide, p-fluoro-L-phenylalanyl-m-bis-(2-chloroethyl)- amino-L-phenylalanyl-methionine ethylester…
Expand
1984
1984
Increased cancericidal activity of PTT.119, a new synthetic bis-(2-chloroethyl)amino-l-phenylalanine derivative with carrier amino acids
M. Yagi
,
J. Bekesi
,
M. Daniel
,
J. Holland
,
A. Barbieri
Cancer Chemotherapy and Pharmacology
1984
Corpus ID: 2065805
SummaryA new synthetic tripeptide (p-F-Phe-m-bis-(2-chloroethyl)amino-Phe-Met ethoxy HCl), PTT.119, was demonstrated to have…
Expand
1983
1983
Differential susceptibility and cytopathic alterations induced by PTT. 119, a new cancericidal compound, p-fluoro-Phe-L-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met ethoxy HCl.
M. Yagi
,
J. Bekesi
Biomedicine & pharmacotherapy = Biomedecine…
1983
Corpus ID: 33698960
PTT.119 is a new synthetic compound under assessment as a chemotherapeutic agent against neoplasia. Exposure of three diverse…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE